Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer

Journal of Clinical Oncology

Volumn 11, Issue 2, 1993, Pages 336-344

  Murray, N ^a   Coy, P ^a   Pater, J L ^a   Hodson, I ^a   Arnold, A ^a   Zee, B C ^a   Payne, D ^a   Kostashuk, E C ^a   Evans, W K ^a   Dixon, P ^a   Sadura, A ^a   Feld, R ^a   Levitt, M ^a   Wierzbicki, R ^a   Ayoub, J ^a   Maroun, J A ^a   Wilson, K S ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0027399457     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.2.336     Document Type: Article

References (0)